Establishing a metabolomic model for the prognosis of hepatitis B virus-induced acute-on-chronic liver failure treated with different liver support systems

Metabolomics

Volumn 7, Issue 3, 2011, Pages 400-412

  Hao, Shaorui ^a   Xin, Jiaojiao ^a   Lian, Jiangshan ^a   Xie, Qing ^a   Chen, Deying ^a   Guo, Yongzheng ^a   Lu, Yingfeng ^a   Sheng, Guoping ^a   Xu, Wei ^a   Huang, Jianrong ^a   Li, Lanjuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Acute on chronic liver failure; Hepatitis B virus; Liver support treatment; Metabolomics

Indexed keywords

AMIDE; BILE ACID CONJUGATE; BILIRUBIN; FATTY ACID; LYSOPHOSPHATIDYLCHOLINE;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; END STAGE LIVER DISEASE; FEMALE; HEMOFILTRATION; HEMOPERFUSION; HEPATITIS B VIRUS; HUMAN; LIVER PROTECTION; LIVER SUPPORT; MALE; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; PLASMAPHERESIS; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

HEPATITIS B VIRUS;

EID: 80051666296     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-010-0260-5     Document Type: Article

References (45)

1. Antoniades, C. G., Berry, P. A., Wendon, J. A., & Vergani, D. (2008). The importance of immune dysfunction in determining outcome in acute liver failure. Journal of Hepatology, 49, 845-861.
2. Bernal, W. (2010). Lactate is important in determining prognosis in acute liver failure. Journal of Hepatology, 53, 209-210.
3. Bernal, W., Donaldson, N., Wyncoll, D., & Wendon, J. (2002). Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: A cohort study. Lancet, 359, 558-563.
4. Boger, D. L., Fecik, R. A., Patterson, J. E., Miyauchi, H., Patricelli, M. P., & Cravatt, B. F. (2000). Fatty acid amide hydrolase substrate specificity. Bioorganic & Medicinal Chemistry Letters, 10, 2613-2616.
5. Chen, Y. S., Wu, Z. W., He, J. Q., Yu, J., Yang, S. G., Zhang, Y. M., et al. (2007). The curative effect of ALSS on 1-month mortality in AoCLF patients after 72 to 120 hours. The International Journal of Artificial Organs, 30, 906-914.
6. Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 384, 83-87.
7. Cravatt, B. F., Saghatelian, A., Hawkins, E. G., Clement, A. B., Bracey, M. H., & Lichtman, A. H. (2004). Functional disassociation of the central and peripheral fatty acid amide signaling systems. Proceedings of the National Academy of Sciences of the United States of America, 101, 10821-10826.
8. Dhiman, R. K., Jain, S., Maheshwari, U., Bhalla, A., Sharma, N., Ahluwalia, J., et al. (2007). Early indicators of prognosis in fulminant hepatic failure: An assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria. Liver Transplantation, 13, 814-821.
9. DI Campli, C., Zocco, M. A., Gaspari, R., Novi, M., Candelli, M., Santoliquido, A., et al. (2005). The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure. Transplantation Proceedings, 37, 2551-2553.
10. Driscoll, W. J., Chaturvedi, S., & Mueller, G. P. (2007). Oleamide synthesizing activity from rat kidney: Identification as cytochrome c. The Journal of Biological Chemistry, 282, 22353-22363.
11. Du, W. B., Li, L. J., Huang, J. R., Yang, Q., Liu, X. L., Li, J., et al. (2005). Effects of artificial liver support system on patients with acute or chronic liver failure. Transplantation Proceedings, 37, 4359-4364.
12. Giang, D. K., & Cravatt, B. F. (1997). Molecular characterization of human and mouse fatty acid amide hydrolases. Proceedings of the National Academy of Sciences of the United States of America, 94, 2238-2242.
13. Huang, Y. H., Schafer-Elinder, L., Wu, R., Claesson, H. E., & Frostegard, J. (1999). Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clinical and Experimental Immunology, 116, 326-331.
14. Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., et al. (2001). A model to predict survival in patients with end-stage liver disease. Hepatology, 33, 464-470.
15. Kim, W. R., Biggins, S. W., Kremers, W. K., Wiesner, R. H., Kamath, P. S., Benson, J. T., et al. (2008). Hyponatremia and mortality among patients on the liver-transplant waiting list. New England Journal of Medicine, 359, 1018-1026.
16. Kjaergard, L. L., Liu, J., Als-Nielsen, B., & Gluud, C. (2003). Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: A systematic review. JAMA, 289, 217-222.
17. Li, N., Li, Q., Qian, Z., Zhang, Y., Chen, M., & Shi, G. (2009). Impaired TLR3/IFN-beta signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: Relevance to the severity of liver damage. Biochemical and Biophysical Research Communications, 390, 630-635.
18. Lin, S. D., Kawakami, T., Ushio, A., Sato, A., Sato, S., Iwai, M., et al. (2006). Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure. Journal of Gastroenterology and Hepatology, 21, 374-380.
19. Lindon, J. C., Nicholson, J. K., & Holmes, E. (Eds.). (2008). The handbook of metabonomics and metabolomics. Beijing: Science Press.
20. Liver Failure and Artificial Liver Group, C. S. O. I. D., Chinese Medical Association & Severe Liver Diseases and Artificial Liver Group, C. S. O. H., Chinese Medical Association. (2006). Diagnostic and treatment guidelines for liver failure. Zhonghua Gan Zang Bing Za Zhi, 14, 643-646.
21. Macquillan, G. C., Seyam, M. S., Nightingale, P., Neuberger, J. M., & Murphy, N. (2005). Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transplantation, 11, 1073-1079.
22. Montejo Gonzalez, J. C., Catalan Gonzalez, M., Meneu Diaz, J. C., Moreno Elola-Olaso, A., De La Cruz, J., & Moreno Gonzalez, E. (2009). Artificial liver support system in acute liver failure patients waiting liver transplantation. Hepato-Gastroenterology, 56, 456-461.
23. O'grady, J. G., Alexander, G. J., Hayllar, K. M., & Williams, R. (1989). Early indicators of prognosis in fulminant hepatic failure. Gastroenterology, 97, 439-445.
24. Olofsson, K. E., Andersson, L., Nilsson, J., & Bjorkbacka, H. (2008). Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages. Biochemical and Biophysical Research Communications, 370, 348-352.
25. 1H magnetic resonance spectroscopy. Metabolomics, 5, 292-301.
26. Polson, J., & Lee, W. M. (2005). AASLD position paper: The management of acute liver failure. Hepatology, 41, 1179-1197.
27. Quinn, M. T., Parthasarathy, S., & Steinberg, D. (1988). Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis. Proceedings of the National Academy of Sciences of the United States of America, 85, 2805-2809.
28. Radu, C. G., Yang, L. V., Riedinger, M., Au, M., & Witte, O. N. (2004). T cell chemotaxis to lysophosphatidylcholine through the G2A receptor. Proceedings of the National Academy of Sciences of the United States of America, 101, 245-250.
29. Ren, F., Chen, Y., Wang, Y., Yan, Y., Zhao, J., Ding, M., et al. (2010). Comparative serum proteomic analysis of patients with acute-on-chronic liver failure: Alpha-1-acid glycoprotein maybe a candidate marker for prognosis of hepatitis B virus infection. Journal of Viral Hepatitis, 17, 816-824.
30. Schiodt, F. V., Ostapowicz, G., Murray, N., Satyanarana, R., Zaman, A., Munoz, S., et al. (2006). Alpha-fetoprotein and prognosis in acute liver failure. Liver Transplantation, 12, 1776-1781.
31. Schiodt, F. V., Rossaro, L., Stravitz, R. T., Shakil, A. O., Chung, R. T., & Lee, W. M. (2005). Gc-globulin and prognosis in acute liver failure. Liver Transplantation, 11, 1223-1227.
32. Schmidt, L. E., & Dalhoff, K. (2002). Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology, 36, 659-665.
33. Schmidt, L. E., & Larsen, F. S. (2010). Is lactate concentration of major value in determining the prognosis in patients with acute liver failure? Hardly. Journal of Hepatology, 53, 211-212.
34. Shepherd, L., Alexander, C., Sungurtas, J., Mcnicol, J., Stewart, D., & Davies, H. (2010). Metabolomic analysis of the potato tuber life cycle. Metabolomics, 6, 274-291.
35. Sun, Q. F., Ding, J. G., Xu, D. Z., Chen, Y. P., Hong, L., Ye, Z. Y., et al. (2009). Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model. Journal of Viral Hepatitis, 16, 464-470.
36. Wei, B. Q., Mikkelsen, T. S., Mckinney, M. K., Lander, E. S., & Cravatt, B. F. (2006). A second fatty acid amide hydrolase with variable distribution among placental mammals. The Journal of Biological Chemistry, 281, 36569-36578.
37. Whitfield, P., Noble, P.-J., Major, H., Beynon, R., Burrow, R., Freeman, A., et al. (2005). Metabolomics as a diagnostic tool for hepatology: Validation in a naturally occurring canine model. Metabolomics, 1, 215-225.
38. Wiklund, S., Johansson, E., Sjostrom, L., Mellerowicz, E. J., Edlund, U., Shockcor, J. P., et al. (2008). Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Analytical Chemistry, 80, 115-122.
39. Xing, T., Li, L., Cao, H., & Huang, J. (2007). Altered immune function of monocytes in different stages of patients with acute on chronic liver failure. Clinical and Experimental Immunology, 147, 184-188.
40. Yamagishi, Y., Saito, H., Ebinuma, H., Kikuchi, M., Ojiro, K., Kanamori, H., et al. (2009). A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis. Journal of Gastroenterology, 44, 615-623.
41. Yamagishi, Y., Saito, H., Tada, S., Horie, Y., Kato, S., Ishii, H., et al. (2005). Value of computed tomography-derived estimated liver volume/standard liver volume ratio for predicting the prognosis of adult fulminant hepatic failure in Japan. Journal of Gastroenterology and Hepatology, 20, 1843-1849.
42. Yang, J., Zhao, X., Liu, X., Wang, C., Gao, P., Wang, J., et al. (2006). High performance liquid chromatography-mass spectrometry for metabonomics: Potential biomarkers for acute deterioration of liver function in chronic hepatitis B. Journal of Proteome Research, 5, 554-561.
43. Yantorno, S. E., Kremers, W. K., Ruf, A. E., Trentadue, J. J., Podesta, L. G., & Villamil, F. G. (2007). MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transplantation, 13, 822-828.
44. Yasumi, Y., Takikawa, Y., Endo, R., & Suzuki, K. (2007). Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatology Research, 37, 248-254.
45. Zaman, M. B., Hoti, E., Qasim, A., Maguire, D., Mccormick, P. A., Hegarty, J. E., et al. (2006). MELD score as a prognostic model for listing acute liver failure patients for liver transplantation. Transplantation Proceedings, 38, 2097-2098.